Efficacy of Different Low Level Laser Therapy Sessions

Myofascial Pain Syndrome Clinical Trial

Official title:

Efficacy of Different Low Level Laser Therapy Sessions in Management of Masseter Muscle Trigger Points

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06327204
• Other study ID #: Low Level laser 24
• Status: Completed
• Phase: N/A
• Start date: March 1, 2023
• Est. completion date: December 1, 2023

Study information

• Verified date: March 2024
• Source: October 6 University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Myofascial pain dysfunction syndrome is one of the common causes of non-odontogenic pain in the head and neck region. It accounts for 40-60% of the adult population. Different treatment modalities had been reported to release the trigger point within the muscles of mastication in order to reduce pain and allow recovery of the function.

Description:

Low-level laser therapy has been a research focus in past few years as it provides effective and conservative treatment modality with minimal patient discomfort. LLLT promotes the release of endogenous opioids, enhance tissue repair and cellular respiration, increase vasodilatation and pain relief Recent systematic review and meta-analysis had reported that the available evidence didn't allow clinicians to draw firm conclusions on effective dosage. This study aimed to investigate the effect of different LLLT sessions' number on pain, maximum mouth opening and quality of life in patients with masseter muscle trigger points.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 90
• Est. completion date: December 1, 2023
• Est. primary completion date: October 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

1. definite diagnosis of myofascial pain based on the DC/TMD criteria with a referral

2. presence of one or more trigger points in the masseter muscle

3. no history of any invasive procedures of the related masseter muscle.

Exclusion Criteria:

1. any painful conditions affecting the orofacial region

2. any systemic diseases that could masticatory function (e.g., rheumatoid arthritis and epilepsy)

3. pregnancy and lactation.

Related Conditions & MeSH terms

• Fibromyalgia
• Myofascial Pain Syndrome
• Myofascial Pain Syndromes

Intervention

Device:
• 940-nm diode laser / one session
laser therapy using a 940-nm diode laser / one session per week
• 940-nm diode laser / two session
laser therapy using a 940-nm diode laser / two session per week
• 940-nm diode laser/ three session
laser therapy using a 940-nm diode laser / three session per week

Locations

Country	Name	City	State
Egypt	Faculty of Dentistry, October 6 University	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
October 6 University

Country where clinical trial is conducted

Egypt, 

References & Publications (2)

Ahrari F, Madani AS, Ghafouri ZS, Tuner J. The efficacy of low-level laser therapy for the treatment of myogenous temporomandibular joint disorder. Lasers Med Sci. 2014 Mar;29(2):551-7. doi: 10.1007/s10103-012-1253-6. Epub 2013 Jan 15. — View Citation

Maia ML, Bonjardim LR, Quintans Jde S, Ribeiro MA, Maia LG, Conti PC. Effect of low-level laser therapy on pain levels in patients with temporomandibular disorders: a systematic review. J Appl Oral Sci. 2012 Nov-Dec;20(6):594-602. doi: 10.1590/s1678-77572012000600002. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	pain score	a 10-point visual analogue score	8 weeks
Secondary	maximum mouth opening	measuring the interincisal distance between the upper and lower central incisors	8 weeks
Secondary	quality of life questioner	Oral Health Impact Profile questionnaire (OHIP-14) containing 14 questions divided into seven domains of oral health	8 weeks